Dangerous 'gray-market' weight-loss drugs flooding US as experts warn of risks
NegativeU.S News

The rise of unregulated GLP-1 weight-loss drugs in the U.S. is alarming experts, especially as high costs and shortages push consumers towards dangerous gray-market options. The FDA has issued warnings about counterfeit Ozempic, highlighting the serious health risks involved. This situation underscores the urgent need for stricter enforcement and regulation to protect consumers from potentially harmful substances.
— Curated by the World Pulse Now AI Editorial System